Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01526538 · ClinicalTrials.gov registry record · Phase 2
Improving Learning-based Treatment of Cocaine Dependence With Medication
A Phase 2 study, sponsored by Johns Hopkins University.
- Completed
- Registry status
- Phase 2
- Development phase
- 52
- Enrollment target
NCT01526538: Completed Phase 2 study, sponsored by Johns Hopkins University.
NCT01526538 is a Phase 2 study that has completed, run by Johns Hopkins University. The registered enrollment target is 52 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01526538, a Phase 2 study, has completed, sponsored by Johns Hopkins University.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 52 participants
- Enrollment target
Study Summary
This study will test the efficacy of d-cycloserine in enhancing response to learning-based treatment for cocaine dependence, specifically contingency management.
Interventions
- DRUG d-cycloserine
- DRUG sugar pill
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 52 participants |
| Start Date | 2011-09 |
| Est. Completion | 2013-03 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01526538
The ClinicalTrials.gov registry entry for NCT01526538 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 52 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Johns Hopkins University, which has 1,448 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which d-cycloserine is the first listed.
NCT01526538 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01526538 about?
NCT01526538 is a clinical study titled "Improving Learning-based Treatment of Cocaine Dependence With Medication". This study will test the efficacy of d-cycloserine in enhancing response to learning-based treatment for cocaine dependence, specifically contingency management.
What is the current status of trial NCT01526538?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 52 participants. The study started on 2011-09. Estimated completion is 2013-03.
What interventions are being tested in trial NCT01526538?
The interventions under investigation include: d-cycloserine (DRUG), sugar pill (DRUG).
Who is sponsoring clinical trial NCT01526538?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.